P
ProVerum
Biotech & Life Sciences · Dublin, Ireland · Founded 2016
Redefining Minimally Invasive Treatment for BPH MoreLess
Proverum is an Irish medical device company founded in 2016 as a spin-off from Trinity College Dublin, developing novel treatment solutions for patients with symptomatic benign prostatic hyperplasia (BPH).
ProVerum has developed a minimally invasive implant for patients with symptomatic Benign Prostatic Hyperplasia (BPH) as an alternative to invasive surgery.
Company overview
ProVerum company information
The essential company record, classifications and operating signals in one place.
- Status
- Operational
- Founded
- 2016
- Headquarters
- Dublin, Ireland
- Employees
- 54
- Open positions
- None listed
- Dealroom signal
- 95.0
Valuation & funding
ProVerum funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES BOther financing | Aug 2025 | $80M | $320M | Enterprise Ireland · OrbiMed · Ireland Strategic Investment Fund · Atlantic Bridge University Fund | ↗ |
| EARLY VCOther financing | Nov 2023 | $17M | $165M | Lightstone Ventures · Irrus Investments · Medtech | — |
| SERIES AOther financing | Jan 2022 | $33M | $132M | Gilde Healthcare · Lightstone Ventures | ↗ |
| GRANTOther financing | Jun 2021 | $0 | — | European Innovation Council | — |
| GRANTOther financing | Dec 2020 | $110K | — | EIT Health | — |
| GRANTOther financing | Jan 2020 | European Innovation Council | — | ||
| SEEDOther financing | May 2018 | Irrus Investments · Halo Business Angel Network · Atlantic Bridge University Fund · Enterprise Ireland | — | ||
| SEEDOther financing | Apr 2017 | Undisclosed | — | ||
| GRANTOther financing | Jul 2016 | EIT Health | — | ||
| GRANTOther financing | Jun 2016 | EIT Health | — |
Financials
Revenue, earnings and profit over time
Reported history and available estimates. Estimated years are marked “E”; sparse fields are left blank rather than inferred.
| Year | Revenue | Growth | EBITDA | Margin |
|---|---|---|---|---|
| 2026 | $1.1M | 0% | −$1.7M | -157.2% |
| 2025 | $1.1M | 0% | −$1.7M | -157.2% |
| 2024 | $1.1M | 0% | −$1.7M | -157.2% |
| 2023 | $1.1M | +6.1% | −$1.7M | -157.2% |
| 2022 | $999K | — | −$1.7M | -166.8% |
| 2021 | — | — | −$1.7M | — |
| 2020 | — | — | −$1.7M | — |
Growth signals
ProVerum website traffic
Latest recorded traffic for ProVerum is 1.4K monthly website visits, up 91.8% over the last three months. ProVerum's team grew 45.9% over the past year.
Hiring
Open positions at ProVerum
Current openings linked to this company in Dealroom.
Comparisons
ProVerum compared with similar companies
Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.
Talent graph
ProVerum's talent
Source: Dealroom Talent Intelligence.
Global footprint
Where ProVerum has talent and traffic
team presence
In the news
Latest news about ProVerum
Recent press, funding announcements, and product moves mentioning ProVerum — open to read from the original sources.
Market sentiment
What the market is saying about ProVerum
An AI-synthesized read of the highest-engagement posts about ProVerum on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See ProVerum’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.